Novartis Foundation

Novartis Foundation
Name	Novartis Foundation
Founded	1979
Founder	Marc Moret
Type	Non-profit foundation
Focus	Global health, healthcare innovation, disease elimination
Headquarters	Basel, Switzerland
Key people	Ann Aerts (former Head)
Parent	Novartis
Website	https://www.novartisfoundation.org/

Novartis Foundation. Established in 1979, it is a philanthropic organization dedicated to transforming global health through science-based innovation. It focuses on developing scalable solutions to combat non-communicable diseases and strengthen health systems in low-income communities. The foundation leverages data, digital health technologies, and novel partnerships to drive sustainable impact.

History

The organization was founded in 1979 by Marc Moret, then chairman of the predecessor company Ciba-Geigy. Initially, its work centered on supporting social projects in Switzerland and providing humanitarian aid following disasters like the Armenian earthquake. A significant evolution occurred in the 1990s, shifting focus toward sustained global health initiatives, particularly in sub-Saharan Africa. Under the leadership of figures like Ann Aerts, it increasingly embraced data science and artificial intelligence to address complex health challenges, moving from traditional grant-making to acting as an innovation engine.

Mission and focus areas

The core mission is to pioneer scalable health models and catalyze policies that improve equity. Primary focus areas include the prevention and control of cardiovascular diseases, the elimination of malaria and leprosy, and the transformation of urban health. A cross-cutting theme is building resilient health systems through the strategic integration of digital tools and predictive analytics. This work often intersects with efforts to address social determinants of health and foster community health worker programs in collaboration with national ministries.

Key programs and initiatives

Notable programs have included the Community-Based Hypertension Improvement Program (ComHIP) in Ghana, which utilized mobile health technology. The Better Hearts Better Cities initiative targeted urban cardiovascular health in settings like Ulaanbaatar, Mongolia and São Paulo, Brazil. In disease elimination, the foundation supported large-scale efforts against lymphatic filariasis and trachoma through mass drug administration campaigns. Its AIMed program applied artificial intelligence to reshape primary care delivery and epidemic preparedness in several countries.

Organizational structure and governance

The foundation operates as a legally independent entity under Swiss law, governed by a board of trustees which includes senior executives from Novartis and external experts in global health. Day-to-day operations are managed by a dedicated executive team, with programmatic work often organized into distinct portfolios like non-communicable diseases and health systems innovation. Its headquarters in Basel coordinates a network of regional teams and advisors working directly in partner countries across Africa, Asia, and Latin America.

Partnerships and collaborations

It functions through multi-sector alliances, partnering with entities like the World Health Organization, the United States Agency for International Development, and the Bill & Melinda Gates Foundation. Collaborations extend to academic institutions such as the University of Cape Town and technology firms like Microsoft. Key implementation partners often include local non-governmental organizations, research institutes, and national ministries of health, such as those in Senegal and Vietnam, to co-design and scale interventions.

Impact and recognition

Its initiatives have contributed to policy changes, including updated national guidelines for hypertension management in Ghana and Vietnam. The foundation's evidence-based approaches have been recognized through publications in journals like The Lancet and invitations to speak at forums like the World Economic Forum. Measurable outcomes include improved blood pressure control rates in urban populations and strengthened surveillance systems for infectious diseases, influencing broader strategies within the global health community.

Category:Medical and health organizations based in Switzerland Category:Organizations established in 1979 Category:Novartis